Genetic Stability Testing Service Companies, Value Chain and Recent Development

Who are the Top Companies and What are Their Offerings in the Genetic Stability Testing Service Market?

Charles River Laboratories

Headquarters: Massachusetts, U.S.
Genetic Stability Testing Services: DNA/RNA sequencing, qPCR, and blotting techniques

Eurofins BioPharma Product Testing

Headquarters: Luxembourg City, Luxembourg
Genetic Stability Testing Services: Comprehensive cell line characterization techniques

Merck KGaA

Headquarters: Darmstadt, Germany
Genetic Stability Testing Services: Aptegra CHO Genetic Stability Assay

Thermo Fisher Scientific

Headquarters: Massachusetts, U.S.
Genetic Stability Testing Services: Ion Torrent and Applied Biosystems

Sartorius AG

Headquarters: Göttingen, Germany
Genetic Stability Testing Services: Bioanalytical services

WuXi Advanced Therapies

Headquarters: Shanghai, China
Genetic Stability Testing Services: Stability testing and cell line characterization techniques

SGS S.A.

Headquarters: Geneva, Switzerland
Genetic Stability Testing Services: Specialized genotoxicity and genetic toxicology testing

QIAGEN N.V.

Headquarters: Venlo, Netherlands
Genetic Stability Testing Services: Molecular testing solutions and sample preparation kits

LabCorp

Headquarters: North Carolina, U.S.
Genetic Stability Testing Services: Comprehensive non-clinical genetic toxicology and stability studies

Illumina, Inc.

Headquarters: California, U.S.
Genetic Stability Testing Services: High-throughput NGS technology

Market Value Chain Analysis

R&D

• The R&D of the genetic stability testing service focuses on the development of next-generation sequencing (NGS) and bioinformatics.
• Key players: Charles River Laboratories, Merck KGaA, Eurofins BioPharma Product Testing.

Clinical Trials and Regulatory Approvals

• The consistency, absence of genetic drifts, and mRNA integrity are verified in the clinical trials and regulatory approvals of the genetic stability testing service.
• Key players: Eurofins BioPharma Product Testing, Charles River Laboratories, Merck KGaA.

Patient Support and Services

• The patient support and services of the genetic stability testing services involve indirect patient support and services, ensuring the safety and long-term efficacy of the cell and gene therapies.
• Key players: Eurofins BioPharma Product Testing, LabCorp.

Market Growth

The global genetic stability testing service market size was estimated at USD 1.35 billion in 2025 and is predicted to increase from USD 1.48 billion in 2026 to approximately USD 3.28 billion by 2035, expanding at a CAGR of 9.24% from 2026 to 2035.

Recent Developments in the Market

• In January 2026, Illumina NovaSeq X was successfully installed at Agilus Diagnostics in Mumbai, which will provide high-throughput sequencing, scalable analytics, and support multi-omic output services to the clinicians and patients, enhancing the development of personalised medicine.
• In May 2025, the world’s first cell analyzer with spectral and real-time cell imaging technologies was launched by Becton, Dickinson and Company, which will identify the cells once invisible in flow cytometry experiments, discovering their dynamics along with deeper insights.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com